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Background and Rationale 
 
International genome sequencing projects have produced billions of nucleotides (letters) of DNA 
sequence data, including the complete genome sequences of 74 organisms.  These genome 
sequences have created many new scientific opportunities, including the ability to identify 
sequence variations among individuals within a species.  These genetic differences, which are 
known as single nucleotide polymorphisms (SNPs), are particularly important in understanding 
the genetic basis for disease susceptibility. 
 
Since the report of the complete human genome sequence, over two million human SNPs have 
been identified, including a large-scale comparison of an entire chromosome from twenty 
individuals.  Of the protein coding SNPs (cSNPs), approximately half leads to a single amino 
acid change in the encoded protein (non-synonymous coding SNPs).  Most of these changes 
are functionally silent, while the remainder negatively impact the protein and sometimes cause 
human disease.  To date, over 550 SNPs have been found to cause single locus (monogenic) 
diseases and many others have been associated with polygenic diseases.  SNPs have been 
linked to specific human diseases, including late-onset Parkinson disease, autism, rheumatoid 
arthritis and cancer. 
 
The ability to predict accurately the effects of these SNPs on protein function would represent a 
major advance toward understanding these diseases.  To date several attempts have been 
made toward predicting the effects of such mutations.  The most successful of these is a 
computational approach called "Sorting Intolerant From Tolerant" (SIFT).  This method uses 
sequence conservation among many similar proteins to predict which residues in a protein are 
functionally important.  However, this method suffers from several limitations.  First, a query 
sequence must have a sufficient number of relatives to infer sequence conservation.  Second, 
this method does not make use of or provide any information on protein structure, which can be 
used to understand how an amino acid change affects the protein. 
 
The experimental methods that provide the most detailed structural information on proteins are 
X-ray crystallography and NMR spectroscopy.  However, these methods are labor intensive and 
currently cannot be carried out on a genomic scale.  Nonetheless, Structural Genomics projects 
are being pursued by more than a dozen groups and consortia worldwide and as a result the 
number of experimentally determined structures is rising exponentially.  Based on the 
expectation that protein structures will continue to be determined at an ever-increasing rate, 
reliable structure prediction schemes will become increasingly valuable, leading to information 
on protein function and disease for many different proteins. 
 
Given known genetic variability and experimentally determined protein structures, can we 
accurately predict the effects of single amino acid substitutions?  An objective assessment of 
this question would involve comparing predicted and experimentally determined structures, 
which thus far has not been rigorously performed.  The completed research leveraged existing 
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expertise at LLNL in computational and structural biology, as well as significant computing 
resources, to address this question.  
 
 
Experimental Approaches and Methods 
 
We have used several computational and experimental approaches to examine the 
relationships between protein sequence, stability and function. Each of the computational and 
experimental strategies was subdivided into high-throughput and detailed approaches.  A 
schematic of the research strategy is shown in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Outline of the complimentary computational and experimental approaches used in the project.  
A subset of mutations associated with hereditary diseases was the subject of experimental (left) and 
computational (right) assessments of protein stability. 
 
The choice of proteins for these analyses was based on three criteria: 1) relevance to 
programmatic interests of DNA repair proteins in BBRP; 2) known associations between mutant 
gene variants (alleles) and cancer risk; and 3) known three-dimensional structures; and 4) 
available epidemiological data.  The proteins chosen for study were Ape1 (Figure 2) and 
XRCC1 (Figure 3), both of which are involved in Base Excision Repair and have been the 
subject of cross-disciplinary research in BBRP, and p53, which is the protein most commonly 
mutated in a wide variety of human cancers. 
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Figure 2.  A schematic representation of the human Ape1 DNA repair protein.  A ribbon diagram 
illustrates the overall structure of the protein, the position of residues that are mutated in disease-
associated variants are shown in red and the active-site metal ions are shown in yellow.  
 
 
 
Figure 3.  Structures of isolated domains of the human XRCC1 DNA repair protein.  The known NMR 
structure of the N-terminal domain (panel A) and the crystallographic structure of the C-terminal BRCT 
domain are shown.  Variant residues in each domain are depicted in red and yellow, respectively. 
 
Computational Studies 
 
In silico mutagenesis.  For each mutation examined, we used the side-chain building program 
SCWRL, which is freely available, that uses statistical populations of amino acid side chain 
conformations (rotamers) in known crystal structures.  Choice of the most common rotamer was 
iterated with a bump-energy calculation to identify the most probable side chain conformation 
that does not result in a steric clash.  This step was followed by energy minimization using a 
molecular mechanics force field, which is implemented in the software package CHARMM.  A 
rapid assessment of the impact of mutations on protein stability was performed with SCWRL. 
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MD simulations.  Molecular Dynamics simulations (MD) involved integrating the classical 
equations of motions of chemical systems using an empirically derived “ball and spring” model 
of the molecules.  One use of MD was as an exploratory computational experiment to identify 
motions, interactions, and transitions that would otherwise not be expected or noticed.  For 
example, in previous work we identified several new mutation-dependent interactions within the 
DNA repair enzyme Ape1, suggesting not only destabilization by reduced substrate-binding 
affinity.  The other major use of MD is as an analytical tool to measure localized perturbations to 
protein stability. 
 
Experimental Studies 
 
In vitro mutagenesis.  For the genes proposed for experimental studies, the coding DNA 
sequence was obtained from the LLNL IMAGE cDNA collection.  Mutant genes will be 
constructed by the overlap PCR method or by site-specific mutagenesis using the QuikChange 
Mutagenesis Kit (Stratagene, La Jolla, CA).  The mutant genes were screened for protein 
expression and for rapid assessment of thermal stability using a novel fluorescence-based 
screen and by the biophysical method of scanning calorimetry for validation of the screen, which 
are outlined below. 
 
Calorimetric studies.  For detailed, quantitative studies of protein thermal stability, proteins were 
highly purified and analyzed by differential scanning calorimetry.  The Ape1 protein was 
expressed in a native form and the XRCC1 domain fragments were expressed as hexa-histidine 
tagged fusions, which are readily purified.  The stability studies were carried out using a highly 
sensitive MicroCal VP-DSC differential scanning calorimeter, which we have used in our earlier 
studies of other disease-causing mutant and engineered protein variants.  For these 
experiments, purified protein (0.5 mg/mL) in phosphate buffer (20 mM NaPO4, 100 mM NaCl, 
pH 7.0) was scanned from 10-90 °C at a scan rate of 60 °C using a medium feedback (gain) 
setting.  The data were baseline subtracted, normalized for molar concentration and transition 
midpoints were determined using Origin software (MicroCal Inc., Northampton, MA). 
 
Results 
 
Computational studies  
In the computational aspects of the project, we performed both high-throughput calculations and 
intensive MD simulations.  We evaluated the ability to assess protein stability using high-
throughput, computational methods on three test proteins with known three-dimensional 
structures and experimentally determined thermal stabilities, including T4 lysozyme, 
Staphylococcal nuclease and lactose repressor.  For these proteins, single amino acid residue 
variants were used to examine the agreement between calculated and experimentally 
determined stability  (~225 total variants).   
 
Our initial method employed the SCWRL (Side Chain With Rotamer Library) program to 
measure only steric clash penalties.  Several limitations of SCWRL are: 1) for surface residues, 
most substitutions do not produce a steric clash; 2) in the core of a protein, changing a residue 
to one of similar or smaller volume may not result in a penalty, even though the resulting cavity 
should decrease stability; and 3) solvation effects, which are thought to be critical, are not taken 
into account.  Despite these limitations, when SCWRL was used to assess protein 
destabilization by core protein residue substitutions in T4 lysozyme, it correctly predicted 
destabilization in 18/24 cases (75%).  Furthermore, SCWRL was able to predict increased 
stabilization by core residue substitutions in 2/3 cases (66%).  Thus, a raw application of 
SCWRL is of some, limited predictive value.  We also evaluated the presence of cavity forming 
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substitutions as a diagnostic of protein stability.  First, buried residues were identified by 
calculating solvent accessible surface area of mutant residues and then, for buried residues, the 
internal volume change for the mutation was calculated.  We found that the prediction of protein 
destabilization through the creation of internal cavities roughly correlated with the experimental 
data for T4 lysozyme and Staphylococcal nuclease.  These results may benefit future studies 
that will employ distinct approaches for assessing potentially destabilizing mutations in the core 
versus surface mutations, which are probably more dependent on solvent interactions. 
 
For the intensive computational studies, molecular dynamics simulations were carried out on 
seven naturally occurring variants of a human DNA repair protein, Ape1.  Mutations were first 
built into the protein structure using the normal protein structure as a template.  MD simulations 
identified specific regions of variant proteins that exhibited increased mobility as a result of the 
substitution.  The differences in structure (indicated by position) and dynamics (indicated by 
color) are shown in Figure 4.  These thermal motions also can be illustrated along a linear 
version of the protein sequence (Figure 5). 
 
 
 
Figure 4.  Backbone structure and dynamics of the Ape1 DNA repair protein and its disease-associated 
variants.  The backbone structures are represented by the position of the traces and the rms fluctuations, 
corresponding to thermal mobility, are indicated in color, with green indicating regions of high mobility and 
red indicating regions of low mobility. 
 
For five variants of Ape1, three of which are associated with increased cancer risk, we 
employed a novel analytical scheme, based on the collective motions of all backbone atoms 
during nanosecond molecular dynamics simulations.  A significant advance was the finding that 
Beernink, P.T. 
03-LW-017 
 
6 
the average backbone rms fluctuation (RMSF) from MD is highly correlated with global stability  
(see below).   
 
 
Figure 5.  Backbone dynamics of Ape1 variant proteins.  The rms fluctuations along the Ape1 backbone 
plotted versus residue number. More flexible, solvent-exposed loops of the protein are visible as peaks in 
the rms profile and more stationary regions constitute the baseline of the plot.  The normal Ape1 protein 
(WT) is represented in thin black line, a relatively unstable variant Ape1 protein, R237C, is shown as a 
blue line and the crystallographic thermal (B) factor is shown as as thick, black line. 
 
To generalize this result, we have extended our initial studies on Ape1 to another biologically 
important protein with many known cancer-causing variants, the p53 tumor suppressor protein.  
We conducted simulations of the normal p53 protein and four p53 variants for a minimum of 50 
picoseconds.  Figure 6 illustrates differences between the active site structures of normal and 
variant p53 proteins as determined by MD simulations.  These studies were partially completed, 
and have generated data that will provide preliminary data that will serve as a basis for follow-on 
funding as well as future studies. 
 
Experimental studies 
 
Construction of variant genes and proteins.  Since most SNPs are predicted to affect protein 
stability, the objective of this component of the project was to evaluate the relationship between 
protein structure and stability.  For a moderate number of human cancer-associated variant 
proteins, including human Ape1 and XRCC1, we constructed a DNA molecule encoding the 
variant protein.  The proteins were expressed either in cell-free reactions for rapid assessment 
of protein stability based on a fluorescent reporter system or in E. coli for large-scale expression 
and subsequent protein purification. 
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Figure 6.  Structural differences in active-site conformations of the core domain of the p53 tumor 
suppressor protein.  Simulations of the normal and C242S variant proteins were conducted for >80 
picoseconds.  Structures indicate a significantly different conformation in the region of the zinc-finger 
motif, resulting in exposure of the sulfur atoms (yellow). 
 
High-throughput protein stability screen.  We designed and implemented a rapid, protein-
stability screen, which is readily scalable to a 96-well microplate format.  This screening method 
is based on a carboxyl-terminal GFP fusion protein, (i.e. a query protein genetically fused to 
GFP), which allows GFP to report on the stability of the upstream sequence.  This method relies 
on a previously established correlation between thermodynamic protein stability and the in vivo 
half-life.  We have demonstrated this method on a destabilized Ape1 variant R237C, which 
exhibits a 7.3 °C reduction in melting temperature compared to the normal (wild-type) protein.  
In the fluorescence-based assay, this variant produces an approximate four-fold reduction in 
fluorescence intensity, which indicates that its in vivo stability is significantly reduced. 
 
Calorimentric studies.  For Ape1 variant proteins and XRCC1 domain fragments, sufficient 
amounts of purified proteins were obtained and measurements of their thermal stability were 
conducted.  The results are shown graphically in Figure 7 and are summarized in Table 1.  
Figure 7 illustrates the relatively high stability of the normal Ape1 protein (blue), which has a 
transition midpoint (Tm) values near 60 °C.  This result contrasted with the relative instability of 
the disease-associated variant proteins P112L (green) and R237C (violet).  Other Ape1 variants 
also were destabilized, though to a lesser extent (Table 1).  The experimental results were 
compared to the predictions obtained through bump energy calculations and MD simulations 
(see below). 
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Figure 7.  Calorimetric measurements of variant protein stability.  The Ape1 DNA repair protein was 
purified from E. coli and scanned in a highly sensitive microcalorimeter.  The change in heat capacity 
(∆Cp) is plotted versus temperature and a peak in the profile corresponds to an endothermic transition.  
The normal protein unfolds with a transition midpoint temperature (Tm) of 48 °C, whereas the variant 
proteins unfold with a Tm value of 41-42 °C. 
 
 
Table 1.  Calorimetric transition temperatures of Ape1 variant proteins. 
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Protein Tma (C) nb Tmc 
Ape1 47.7 (±1.2) 4 --- 
L104R 41.3 1 -6.6 
P112L 42.4 (±0.2) 5 -5.3 
E126D 44.1 1 -3.8 
D148E 42.8 2 -5.1 
R237A 34.9 (±0.8) 3 -12.8 
R237C 40.4 (±0.5) 5 -7.3 
a transition midpoint 
b number of experiments 
c change in Tm relative to wild-type Ape1
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Correlation of computational and experimental studies 
 
Through comparison of our computational and experimental studies, we have shown a close 
correlation between theory and experiment.  The average backbone rms fluctuations were 
shown to be correlated with the thermal stability of the protein, as indicated by the calorimetric 
thermal transition temperature (Figure 8).  This correlation has been further validated using two 
additional Ape1 variants, which are not depicted in the Figure.  
 
Based on a physical concept known as the Lindemann Criterion1, we have derived a physical 
model for this relationship.  This result is of considerable significance, since experimental 
studies are labor-intensive and computational power is continually increasing.  Thus for disease-
causing proteins of known (or potentially modeled) three-dimensional structure, an evaluation of 
the effects of sequence variation on the protein is possible.  Since many regions in the protein 
can influence its stability, whereas relatively few contribute directly to functional activity, this 
type of analysis could identify variants that impact protein stability and indirectly on protein 
function. 
 
To provide a greater number of data points to support this correlation and to prove that the 
method is general for proteins, we have extended our earlier studies through simulation of the 
single most important cancer-causing protein, p53.  This protein has a known three-dimensional 
structure and 36 known variants.  We have performed MD simulations on five variants of this 
protein and have compared the results with those obtained previously on Ape1.  Following side-
chain building and energy minimization using CHARMM, MD simulations (ca. 104 atoms 
including solvent) are performed for a duration of 1 ns.  The MD trajectories are analyzed using 
CHARMM to obtain the RMS fluctuation for backbone atoms over the entire simulation.  The 
resulting data on 5 or more variants of three different proteins will represent a thorough 
assessment of this potentially powerful computational tool. 
 
 
 
                                                 
1 
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T  =              < ∆x2 >
          Ćρ  kB3 where E is Young’s Modulus, ρ is protein density and x is the RMSF 
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Figure 8.  Correlation of experimentally measured and computationally derived protein stability.  
Experimental stability (∆Tm) is plotted on the ordinate and mean backbone RMSF is shown on the 
abscissa.  The R2 correlation value for a quadratic fit is 0.96. 
 
 
Outcomes 
 
In summary, we made substantial advances in both computational and experimental 
components of this project.  Through this LDRD project, we have demostrated an association 
between disease-causing protein variants and thermal stability.  Furthermore, we have shown a 
close correlation between experimentally measured and computationally derived protein stability 
and thus have developed a novel use of MD in quantifying changes in protein stability due to 
mutations. 
 
One manuscript based on this work has been published  (Beernink, PT et al., J. Biol. Chem. 
(2005) Aug 26; 280(34): 30206-13.  Two additional manuscripts are in preparation (Hadi et al., 
2006; Barsky et al., 2006) and will soon be submitted to peer-reviewed journals (projected date 
early 2006).  One grant proposal has been submitted to NIH (on 7/1/04) and two grant 
proposals have been submitted to DOD Congressionally Directed Medical Research Programs 
(CDRMP) for breast and prostate cancer-related research.  At least one additional grant 
proposal based on this work is planned. 
 
